Martin van den Bent - Biography#

Prof dr Martin J. van den Bent is trained as a neurologist. He joined in 1992 the Neuro-Oncology Unit of Erasmus MC Cancer Center in Rotterdam, the Netherlands. In 2007 he became professor of Neuro-Oncology at Erasmus University. He has been the principle investigator of many international multicenter phase II and III trials on both high and low grade glial tumors that contributed to the standard of care of glioma patients. From 2003 to 2009 he was the chair of the EORTC Brain Tumor Group, from 2012 to 2018 he served as a board member of the EORTC. Between 2018 and 2020 he was president of the European Association of NeuroOncology. From 2020 to 2022 he served as the chair of the EANO guideline committee, of which committee he is now a regular member. Prof van den Bent served on several ASCO committees including the CNS guideline committee. He is one of the coordinating members of the Response Assessment in Neuro-Oncology (RANO) group. He authored many manuscripts on neuro-oncological topics and wrote many chapters in textbooks on neuro-oncology. He is the recipient of several SNO awards for Excellence in Clinical Research and the 2015 European CanCer Organisation Clinical Research Award. He organized between 2006 and 2015 the bi-annual EORTC-EANO-ESMO Trends in Central Nervous System Malignancies. In 2023, he was the president of the EANO annual congress, held in Rotterdam, the Netherlands.